罗氏Gazyva/Gazyvaro治疗系统性红斑狼疮的III期试验达到主要终点——临床试验竞技场
Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint Clinical Trials Arena
Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint Clinical Trials Arena
Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint Clinical Trials Arena